Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study.
Bin ZhuBinhua DongSimei HongMeihua WangWeichao DaiQingzhu ZhengDan WuYingping CaoPublished in: Risk management and healthcare policy (2020)
Combined ACTN4 and SCC-Ag detection is a promising serological biomarker for patients with CIN3 or worse.